Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Contineum Therapeutics (CTNM) Prepaid Assets: 2023-2024

Historic Prepaid Assets for Contineum Therapeutics (CTNM) over the last 2 years, with Dec 2024 value amounting to $1.6 million.

  • Contineum Therapeutics' Prepaid Assets rose 104.55% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year increase of 104.55%. This contributed to the annual value of $1.6 million for FY2024, which is 35.29% down from last year.
  • Per Contineum Therapeutics' latest filing, its Prepaid Assets stood at $1.6 million for FY2024, which was down 35.29% from $2.5 million recorded in FY2023.
  • Over the past 5 years, Contineum Therapeutics' Prepaid Assets peaked at $2.5 million during FY2023, and registered a low of $1.6 million during FY2024.
  • In the last 2 years, Contineum Therapeutics' Prepaid Assets had a median value of $2.1 million in 2023 and averaged $2.1 million.
  • Data for Contineum Therapeutics' Prepaid Assets shows a maximum YoY slumped of 35.29% (in 2024) over the last 5 years.
  • Contineum Therapeutics' Prepaid Assets (Yearly) stood at $2.5 million in 2023, then plummeted by 35.29% to $1.6 million in 2024.